PE firm ChrysCapital acquires Swiss parent’s stake in Novartis India
· thehindubusinessline.com
ChrysCapital acquires a 70.68% stake in Novartis India in a ₹1,446 crore deal, appoints new leadership and targets growth in branded generics.
Private equity firm ChrysCapital has acquired a controlling 70.68 per cent stake in Novartis India Limited (NIL), previously held by the parent company, Swiss d...